3SBio Inc Shs Unitary 144A/Reg S 01530
Trading Information
- Previous Close Price
- HKD 6.27
- Day Range
- HKD 6.14–6.30
- 52-Week Range
- HKD 4.91–7.97
- Bid/Ask
- HKD 6.18 / HKD 6.20
- Market Cap
- HKD 14.82 Bil
- Volume/Avg
- 5.9 Mil / 10.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 7.31
- Price/Sales
- 1.77
- Dividend Yield (Trailing)
- 1.59%
- Dividend Yield (Forward)
- 3.99%
- Total Yield
- 1.59%
Company Profile
3SBio Inc, or 3SBio is a biotechnology company. As a pioneer in the Chinese biotechnology industry, the Group has extensive expertise in researching, developing, manufacturing, and marketing biopharmaceuticals. The core products of the Group include several biopharmaceutical drugs, TPIAO recombinant human erythropoietin rhEPO products EPIAO and SEPO, Yisaipu, Cipterbin, and a small molecule drug, Mandi. Except for minoxidil, an over-the-counter drug, the others are all older-generation biologics. The majority of its pipeline candidates are "me-too" drugs and in general, are still at an early stage.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Value
- Total Number of Employees
- 5,411
- Website
- https://www.3sbio.com
Comparables
Valuation
|
Metric
|
01530
|
02181
|
02171
|
|---|---|---|---|
Price/Earnings (Normalized) | 7.31 | — | — |
Price/Book Value | 0.97 | 9.90 | 1.87 |
Price/Sales | 1.77 | 15.61 | — |
Price/Cash Flow | 6.52 | — | — |
Price/Earnings
01530
02181
02171
Financial Strength
|
Metric
|
01530
|
02181
|
02171
|
|---|---|---|---|
Quick Ratio | 2.20 | 0.69 | 9.49 |
Current Ratio | 2.47 | 1.08 | 9.55 |
Interest Coverage | 9.60 | −20.87 | −174.85 |
Quick Ratio
01530
02181
02171
Profitability
|
Metric
|
01530
|
02181
|
02171
|
|---|---|---|---|
Return on Assets (Normalized) | 7.98% | −20.43% | −28.70% |
Return on Equity (Normalized) | 13.60% | −79.65% | −35.29% |
Return on Invested Capital (Normalized) | 9.06% | −38.37% | −35.38% |
Return on Assets
01530
02181
02171
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| Qxwvvlvb | Vpzndl | $124.1 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Pysqyqcq | Tpgklhz | $114.2 Bil | |||
| Moderna Inc
MRNA
| Gccqprf | Tygr | $53.7 Bil | |||
| argenx SE ADR
ARGX
| Rkrpclzc | Kgyf | $23.0 Bil | |||
| BioNTech SE ADR
BNTX
| Nqvhsjns | Xqjfg | $22.2 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Hhdwsckkx | Ydlwld | $20.3 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Dgxjzvsn | Dzwnyb | $15.9 Bil | |||
| United Therapeutics Corp
UTHR
| Hrxlggh | Pdrv | $12.8 Bil | |||
| Incyte Corp
INCY
| Msjnmxsjt | Yxwdsqq | $12.2 Bil | |||
| Royalty Pharma PLC Class A
RPRX
| Vsyfnhljm | Mhvgj | $12.2 Bil |